N-[4-[5-(4-fluorophenyl)-2-(furan-2-yl)-1H-imidazol-4-yl]-2-pyridinyl]cyclopropanecarboxamide
C22H17FN4O2 — CID 155538694
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[5-(4-fluorophenyl)-2-(furan-2-yl)-1H-imidazol-4-yl]-2-pyridinyl]cyclopropanecarboxamide
N-[4-[5-(4-fluorophenyl)-2-(furan-2-yl)-1H-imidazol-4-yl]-2-pyridinyl]cyclopropanecarboxamide (PubChem CID 155538694) has the molecular formula C22H17FN4O2 and a molecular weight of 388.40 g/mol. Its IUPAC name is N-[4-[5-(4-fluorophenyl)-2-(furan-2-yl)-1H-imidazol-4-yl]-2-pyridinyl]cyclopropanecarboxamide.
Molecular Properties
| Compound Name | N-[4-[5-(4-fluorophenyl)-2-(furan-2-yl)-1H-imidazol-4-yl]-2-pyridinyl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 155538694 |
| Molecular Formula | C22H17FN4O2 |
| Molecular Weight | 388.40 g/mol |
| Exact Mass | 388.13 |
| IUPAC Name | N-[4-[5-(4-fluorophenyl)-2-(furan-2-yl)-1H-imidazol-4-yl]-2-pyridinyl]cyclopropanecarboxamide |
| SMILES | O=C(Nc1cc(-c2nc(-c3ccco3)[nH]c2-c2ccc(F)cc2)ccn1)C1CC1 |
| InChI | InChI=1S/C22H17FN4O2/c23-16-7-5-13(6-8-16)19-20(27-21(26-19)17-2-1-11-29-17)15-9-10-24-18(12-15)25-22(28)14-3-4-14/h1-2,5-12,14H,3-4H2,(H,26,27)(H,24,25,28) |
| InChIKey | WSBSGWDWALJLJA-UHFFFAOYSA-N |
| XLogP | 4.89 |
| TPSA | 83.81 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 388.40 |
| LogP ≤ 5 | 4.89 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155538694 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.